The 12th Annual BIO Investor Forum assembles a select group of private, late-stage and venture-stage growth companies, established and emerging public biotechs, and top public and private equity investors to explore investment trends and opportunities in life sciences. Since 2011, 44% of all US therapeutic IPO companies participated in a BIO Investor Forum event as a private company!
In addition to expert-led workshops and panel discussions focusing on industry trends, the conference features presentations by over 100 biotech companies poised to join the growth “watch list” in 2014, as well as a number of nonprofit and venture philanthropy organizations. Organizations who are interested in presenting can submit an application here, and will be contacted shortly about their presentation status.
Now a staple at the Investor Forum, the 12th annual event will once again be featuring a series of Discovery Track presentations. A pricing level has been created for "pre-emerging" biotech companies wishing to participate in the BIO Investor Form. The presentations will focus on Seed and A-round companies incorporated after 2007 that have raised less than $25M total through October 2013. Companies in this track are also first-time presenters at this event and use biotechnology or related technologies for research and development of drug products or diagnostics. The typical audience for all presentations features public and private equity investors, as well as research analysts, investment bankers and industry executives.
What People Are Saying About the BIO Investor Forum
"One of the most productive investor conferences I have attended."
"The BIO Investor Forum is a user-friendly platform that attracts the who's who of biotech and biotech investors!"
"I would urge more companies from outside the US to attend so that they benefit as much as our organization did."
"An essential meeting for the year."
For any questions regarding company presentations, contact Sondra at email@example.com.